In results published in the journal, Neurology, researchers uncovered significant evidence that hormone therapy treatments in early menopause reduce the risk of Alzheimer’s disease by as much as 30 percent.
Researchers of a population based in Cache County in Utah found that women who began hormone replacement therapy within five years of menopause had a 30 percent decreased risk of Alzheimer’s disease, especially when use persisted in excess of ten years. However, women who started hormone replacement therapy five years or more after menopause did not have a reduced risk of Alzheimer’s disease.
Read more from Dr. Jennifer Landa on AskDrManny.com: